Title: Bioinformatics and Systems Biology: An Overview
Author: Eric Werner, Ph.D.
A short overview and perspective on present and future trends in bioinformatics
and systems biology aimed at CEO's and decision makers involved in strategic
development of biotechnology and pharmaceutical companies is presented.
The emphasis is not on details; some reviews are cited for that, but rather
on the vision of where we are heading and to assist the decision maker
in strategic planning of research and development. Research budgets can
be in the hundreds of millions and billions of dollars. No CEO or decision
maker can afford to be ignorant of the broad directions of the software
tools that may help the company to position itself in rapidly evolving
fields such as biotechnology and pharmaco-genomics. Indeed, brand new
markets are opening up that offer unprecedented opportunities as well
as giant challenges to traditional pharmaceutical and biotech companies.
Much like the beginnings of the PC market, large corporations will loose
market share and even be replaced entirely if they do not face up and
adapt to these challenges.